THE USE OF HYDRAZINE SULFATE IN OPTIMIZATION OF PALLIATIVE MEDICAL THERAPY AND IMPROVEMENT OF QUALITY OF LIFE IN CANCER PATIENTS
https://doi.org/10.17650/2220-3478-2014-0-2-13-17
Abstract
The article discusses the quality of life and the necessity of optimization of medical therapy in patients with cancer receiving palliative care. The mechanisms of action and efficacy of the use of hydrazine sulfate in cancer patients.
About the Authors
S. V. Strazhev
Oncology Dispensary of the Moscow Clinical Hospital No. 57
Russian Federation
Russian Federation
A. Yu. Berezantsev
Oncology Dispensary of the Moscow Clinical Hospital No. 57
Russian Federation
Russian Federation
T. V. Karandeeva
Oncology Dispensary of the Moscow Clinical Hospital No. 57
Russian Federation
Russian Federation
A. A. Drobyazko
Oncology Dispensary of the Moscow Clinical Hospital No. 57
Russian Federation
Russian Federation
References
1. Fallowfield L. The quality of life: the missing measurement in health care. London: Souvenir Press, 1990.
2. Ионова Т. И., Новик А. А., Сухонос Ю. А. Качество жизни онкологических больных. Вопросы онкологии 1998;44(6):749–52.
3. Бурковский Г. В., Левченко Е. В., Беркман А. М. Об исследованиях здоровья и качества жизни. Обзор психиатрии и медицинской психологии им. В. М. Бехтерева 2004;1:27–8.
4. Бухтояров О. В., Архангельский А. Е. Психогенный кофактор канцерогенеза. Возможности применения гипнотерапии. СПб.: Алетейя, 2008. 264 с.
5. Бехер О. А. Нервно-психические расстройства у женщин, страдающих раком молочной железы. Автореф. дис. … канд. мед. наук. Томск, 2007. 24 с.
6. Ноlland J. Psycho-oncology: overview, obstacles and opportunities. Psychooncology 1993;1(1):1–13.
7. Ganz P. A., Desmond K. A., Leedham B. et al. Quality of life in long-term disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 2002;94(1):39–49.
8. Schou I., Ekeberg O., Karesen R. Psychosocial intervention as a component of routine breast cancer care – who participates and does it help? Psychooncology 2008;17(7):716–20.
9. Kissan D. W., Maj M., Sartorius N. Depression and cancer. World Psychiatric Association, 2010. 258 p.
10. Галиуллина С. Д. Нервно-психические нарушения у больных раком молочной железы. Дис. … канд. мед. наук. Уфа, 2000. 130 с.
11. Hersh J., Juraskova I., Price M., Mullan B. Psychosocial intervention and quality of life in gynaecological cancer patients: a systematic review. Psychooncology 2009;18:895–910.
12. Jacobsen P. B., Jim H. S. Psychological intervention for anxiety and depression in adult cancer patients: achievememts and challenges. CA Cancer J Clin 2008;58(4):214–30.
13. Walton L. M., Reeve J., Brown P. M. et al. Gynecologic cancer patients’ need and experiences of supportive health services in New Zeland. Psychooncology 2010;19(2):201–8.
14. Salander P. Motives that cancer patient in oncological care have for consulting a psychologist – an empirical study. Psychooncology 2010;19(3):248–54.
15. Whitford H. S., Olver I. N., Peterson M. J. Spirituality is a core domain in the assessment of quality of life in oncology. Psychooncology 2008;17(11):1121–8.
16. D’Souza R. The science of well-beingspiritual values and well-being: a need in mental health care. WPA Regional Meeting SPb 2010 Materials. S.-Petersburg, 2010. P. 151.
17. Pi E. H. The role of spirituality in psychiatric care. WPA Regional Meeting SPb 2010 Materials. S.-Petersburg, 2010. P. 153.
18. Cotton S. P., Levine E. G., Fitzpatrick C. M. et al. Exploring the relationship among spiritual well-being, quality of life, and psychological adjustment in women with breast cancer. Psychooncology 1999;8(5):429–38.
19. Сole B., Pargament K. Re-creating your life: a spiritual / psychotherapeutic intervention for people diagnosed with cancer. Psychooncology 1999;8(5):395–407.
20. Spiegel D. Mind matters in cancer survival. Psychooncology 2012;21:588–93.
21. Филов В. А. Сегидрин – противо опухолевый препарат нового типа. Вопросы онкологии 1994; 40(1–3):3–14.
22. Филов В. А. Основные эффекты и механизмы действия сегидрина. Русский медицинский журнал 2002;10(24):1135–8.
23. Филов В. А., Данова Л. А., Гершанович М. Л. и др. Результаты клинического изучения препарата гидразинсульфат. Вопросы онкологии 1990;36(6):721–6.
24. Filov V. A., Gershanovich M. L., Danova L. A., Ivin B. A. Experience of the treatment with Sehydrin (Hydrazine Sulfate, HS) in the advanced cancer patients. Invest New Drugs 1995;13(1):89–97.
25. Стуков А. Н., Разумейко О. Б., Филов В. А. О несовместимости гидразин сульфата с этанолом и барбитуратами. Деп. ВИНИТИ № 1706–75. Деп. 1975.
Review
Views:
1332
Email this article 